ABMD Stock Ownership Activity

ABIOMED INC 13F holders

No value investing guru has made any change to the ABIOMED INC (ABMD) position according to the gurus' latest SEC quarterly report(s).

Which gurus or hedge funds are buying ABMD now?

According to the latest SEC filing(s) ABIOMED INC (ABMD) has not been purchased by any super investor.

To see more about who is investing in ABIOMED INC (ABMD), please go to the ABMD ownership page.

2022 Q1 (1 result)
Ole Andreas Halvorsen
-100.00%
-82,572
-0.12%
0.00%
Current price: $381.02 6.08% Reported price*: $359.17
2021 Q4 (1 result)
Ole Andreas Halvorsen
buy
+82,572
+0.09%
0.00%
Current price: $381.02 6.08% Reported price*: $359.17
2019 Q3 (1 result)
David Rolfe
-100.00%
-1,000
-0.02%
0.00%
Current price: $381.02 46.55% Reported price*: $260.00
2019 Q2 (1 result)
David Rolfe
buy
+1,000
+0.02%
0.00%
Current price: $381.02 46.55% Reported price*: $260.00
2018 Q4 (1 result)
James Crichton
-100.00%
-150,000
-3.07%
0.00%
Current price: $381.02 15.28% Reported price*: $449.75
2018 Q3 (1 result)
James Crichton
buy
+150,000
+2.62%
0.00%
Current price: $381.02 15.28% Reported price*: $449.75
2014 Q4 (1 result)
Chase Coleman III
-100.00%
-1,690,000
-0.50%
0.00%
Current price: $381.02 1,434.50% Reported price*: $24.83
2014 Q2 (1 result)
Chase Coleman III
buy
+1,690,000
+0.60%
0.60%
Current price: $381.02 1,415.58% Reported price*: $25.14
8 of 8

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.